Frazier Life Sciences Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $475M | Buy |
|
|||||
|
2025
Q2 | $301M | Buy |
|
|||||
|
2025
Q1 | $330M | Buy |
|
|||||
|
2024
Q4 | $409M | Buy |
|
|||||
|
2024
Q3 | $213M | Buy |
|
|||||
|
2024
Q2 | $235M | Hold |
|
|||||
|
2024
Q1 | $289M | Buy |
|
|||||
|
2023
Q4 | $136M | Hold |
|
|||||
|
2023
Q3 | $112M | Buy |
|
|||||
|
2023
Q2 | $129M | Buy |
|
|||||
|
2023
Q1 | $126M | Hold |
|
|||||
|
2022
Q4 | $102M | Buy |
|